ZIOPHARM Oncology, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/08/2021 | Q3 2021 | -$0.13 | -$0.11 | 0.02 | $398,000 | |
08/13/2021 | Q2 2021 | -$0.12 | -$0.11 | 0.01 | $0 | |
05/06/2021 | Q1 2021 | -$0.10 | -$0.10 | 0 | $0 | |
03/01/2021 | Q4 2020 | -$0.11 | $0 | |||
11/05/2020 | Q3 2020 | -$0.09 | -$0.10 | -0.01 | $0 | |
08/06/2020 | Q2 2020 | -$0.09 | -$0.09 | 0 | $0 | |
05/07/2020 | Q1 2020 | -$0.08 | -$0.09 | -0.01 | $0 | |
03/02/2020 | Q4 2019 | -$0.08 | -$0.09 | -0.01 | $0 | |
11/07/2019 | Q3 2019 | -$0.09 | -$0.43 | -0.34 | $0 | |
08/08/2019 | Q2 2019 | -$0.08 | -$0.09 | -0.01 | $0 | |
05/08/2019 | Q1 2019 | -$0.08 | -$0.08 | -0 | $0 | |
03/05/2019 | Q4 2018 | -$0.11 | -$0.08 | 0.03 | $0 | |
11/09/2018 | Q3 2018 | -$0.11 | -$0.09 | 0.02 | $0 | |
08/08/2018 | Q2 2018 | -$0.12 | -$0.09 | 0.03 | $0 | |
05/10/2018 | Q1 2018 | -$0.13 | -$0.11 | 0.02 | $146,000 | |
03/01/2018 | Q4 2017 | -$0.14 | -$0.09 | 0.05 | $1.60 M | |
11/06/2017 | Q3 2017 | -$0.14 | -$0.09 | 0.05 | $1.60 M | |
07/31/2017 | Q2 2017 | -$0.13 | -$0.09 | 0.04 | $1.60 M | |
05/01/2017 | Q1 2017 | -$0.12 | -$0.12 | 0 | $1.60 M | |
02/16/2017 | Q4 2016 | -$0.11 | -$0.09 | 0.02 | $1.60 M |
ZIOPHARM Oncology, Inc. Earnings: Frequently Asked Questions
-
When is ZIOPHARM Oncology, Inc.'s earnings date?
ZIOPHARM Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 23rd, 2022 based off last year's report dates.
-
Did ZIOPHARM Oncology, Inc. beat their earnings estimates last quarter?
In the previous quarter, ZIOPHARM Oncology, Inc. (:ZIOP) reported $-0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.02.
-
How can I listen to ZIOPHARM Oncology, Inc.'s earnings conference call?
The conference call for ZIOPHARM Oncology, Inc.'s latest earnings report can be listened to online.
-
How can I read ZIOPHARM Oncology, Inc.'s conference call transcript?
The conference call transcript for ZIOPHARM Oncology, Inc.'s latest earnings report can be read online.
-
How much profit does ZIOPHARM Oncology, Inc. generate each year?
ZIOPHARM Oncology, Inc. (:ZIOP) has a recorded net income of $0. ZIOPHARM Oncology, Inc. has generated $-0.38 earnings per share over the last four quarters.
-
What is ZIOPHARM Oncology, Inc.'s price-to-earnings ratio?
ZIOPHARM Oncology, Inc. (:ZIOP) has a price-to-earnings ratio of -2.27 and price/earnings-to-growth ratio is -0.05.